CurrentUnitedHealthcarePolicy ENT 004.38

Cochlear Implants

Defines coverage, coding, and benefit considerations for cochlear implant procedures and components for UnitedHealthcare members, referencing InterQual criteria for medical necessity and distinguishing pediatric and adult indications.

Policy Summary

PayerUnitedHealthcare

PolicyCochlear Implants

Policy CodePolicy ENT 004.38

Change TypeRevised documentation requirements

Effective DateAug 1, 2025

Next Review Date

Key ActionSubmit prior authorization using InterQual CP: Procedures, Cochlear Implantation and include medical records documenting treatments tried/failed or contraindicated with dates, duration, and reason for discontinuation plus all recent relevant imaging and diagnostic test results.

SourceLink

POLICY UPDATE CHANGES

Medical Records Documentation Used for Review updated to require 'treatments tried, failed, or contraindicated; include the dates, duration, and reason for discontinuation' and 'all recent applicable imaging studies and diagnostic tests'.

InterQualMedical necessity criteria source

69930, L8614-L8628, V5273Key codes listed

<6 mo / <9 moAge limits noted

DMEExternal parts benefit

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria for Cochlear Implants

Covered with criteria

Covered when ALL of the following high-level conditions are met; detailed clinical eligibility is governed by the InterQual CP: Procedures, Cochlear Implantation (adult and pediatric versions).

Adult non-hybrid cochlear implant: Non-hybrid cochlear implantation is proven and medically necessary under certain circumstances for bilateral sensorineural hearing loss and/or for single-sided or asymmetric sensorineural hearing loss in adults.age >= 18

Refer to InterQual CP: Procedures, Cochlear Implantation (adult) for specific clinical criteria and documentation requirements.

Pediatric non-hybrid cochlear implant: Non-hybrid cochlear implantation is proven and medically necessary under certain circumstances for bilateral sensorineural hearing loss in children ages 6 months and older and for single-sided or asymmetric sensorineural hearing loss in children ages 9 months and older.age >= 6 months for bilateral; age >= 9 months for single-sided/asymmetric

Refer to InterQual CP: Procedures, Cochlear Implantation (pediatric) for specific clinical criteria and documentation requirements. Cochlear implantation for ages below these thresholds is considered experimental/investigational due to lack of FDA approval.

Hybrid cochlear implant (adults): Hybrid cochlear implantation is proven and medically necessary under certain circumstances for sensorineural hearing loss in adults.age >= 18

Refer to InterQual CP: Procedures, Cochlear Implantation for specific clinical criteria for hybrid devices.

Non-hybrid cochlear implantation is considered proven and medically necessary under specified clinical circumstances for adults and children when the InterQual clinical criteria are met. For adults (age 18 and older), non-hybrid cochlear implantation may be appropriate for bilateral sensorineural hearing loss and for single-sided or asymmetric sensorineural hearing loss per InterQual CP: Procedures, Cochlear Implantation. In pediatric patients, non-hybrid cochlear implantation may be considered medically necessary for bilateral sensorineural hearing loss in children age 6 months or older, and for single-sided or asymmetric sensorineural hearing loss in children age 9 months or older. These age thresholds reflect the policy’s alignment to FDA approvals and the InterQual criteria referenced for full clinical detail.

Frequency modulated (FM) systems are not covered as part of cochlear implant services; they are considered accessories that do not meet the definition of a covered health care service and are excluded from coverage. External components of cochlear implants (for example, speech processors, microphones, and transmitter coils) are considered under the durable medical equipment benefit, while implantable components are considered under the medical-surgical benefit—refer to the member-specific benefit plan to determine applicable DME repair/replacement coverage.

This policy uses FDA age-based limits to define experimental or investigational status for certain pediatric cochlear implant indications. Specifically, cochlear implantation for bilateral SNHL in children younger than 6 months of age and for single-sided or asymmetric SNHL in children younger than 9 months is classified as experimental or investigational due to lack of FDA approval. When patients are younger than these FDA-specified ages, the procedure is not considered medically necessary under this policy and InterQual criteria do not override the FDA-based investigational classification.

Procedure and Supply Codes

Applicable procedure and supply codesmixed

69930	Cochlear device implantation; with or without mastoidectomy.
L8614	Cochlear device, includes all internal and external components.
L8615	Headset/headpiece for use with cochlear implant device, replacement.
L8616	Microphone for use with cochlear implant device, replacement.
L8617	Transmitting coil for use with cochlear implant device, replacement.
L8618	Transmitter cable for use with cochlear implant device or auditory osseointegrated device, replacement.
L8619	Cochlear implant external speech processor and controller, integrated system, replacement.
L8627	Cochlear implant; external speech processor, component; replacement.
L8628	Cochlear implant, external controller component; replacement.
V5273	Assistive listening device, for use with cochlear implant

Provider Actions, Prior Authorization & Documentation

Prior Authorization

InterQual-based medical necessity requirement

Prior authorization/medical necessity assessment for cochlear implantation is governed by the InterQual® Clinical Practice (CP) criteria: Procedures, Cochlear Implantation. Providers must obtain prior authorization when required by the member's plan and submit documentation demonstrating that the member meets InterQual medical necessity criteria for the requested cochlear implant procedure.

Applies to adult and pediatric members per InterQual criteria
Refer to the specific InterQual pathway (adult vs pediatric) for age- and indication-specific requirements

Documentation Required

Medical records documentation may be required

Providers are responsible for obtaining and submitting complete medical records to support the prior authorization or claims review. Medical records documentation may be requested to determine whether the member meets the clinical criteria and to verify benefit coverage under the member-specific plan document. Submission of medical records does not guarantee coverage.

Background

Sensorineural hearing loss (SNHL) results from damage to the inner ear (cochlea) or the auditory nerve pathways and is typically permanent. Cochlear implantation is an established treatment option for individuals with significant SNHL when specific clinical criteria are met; this policy references the InterQual CP: Procedures, Cochlear Implantation for the detailed medical necessity criteria that guide patient selection and authorization.

Key Definitions

Sensorineural Hearing Loss (SNHL)

TermSensorineural Hearing Loss (SNHL)

DefinitionOccurs when there is damage to the inner ear (cochlea), or to the nerve pathways from the inner ear to the brain.

PrognosisMost of the time, SNHL cannot be medically or surgically corrected.

FrequencyThis is the most common type of permanent hearing loss.